Adopting an AI-forward approach to the R&D IT ecosystem means moving beyond experimentation to embedding AI into core business processes across safety, regulatory, quality, and medical affairs.

Real-world impact depends on more than deploying models—it requires integration into workflows, data harmonization, and user trust. A platform-first approach, underpinned by strong data governance and cloud scalability, ensures AI becomes a true co-pilot across functions. As pharma companies evolve toward digital maturity, operationalizing AI across the R&D value chain will be a critical lever for speed, compliance, and innovation.